天境生物科技（上海）有限公司 IMab
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
I-Mab Biopharma and Bio-Cancer Treatment International Announce Intention for Collaboration on Arginine Depletion Therapy and Biomarker Study, with Plans for I-Mab to Establish a Translational Medicine Lab in Hong Kong 2019-02-01 17:46
I-Mab Receives IND Approval from the US FDA to Initiate Clinical Trials for Its Proprietary TJC4, a Potential Global Best-in-Class Anti-CD47 Monoclonal Antibody 2019-01-28 21:58
I-Mab Biopharma Receives U.S. FDA IND Clearance for Proprietary CD73 Antibody TJD5 2019-01-22 22:04
I-Mab Receives U.S. FDA IND Approval for Proprietary Anti-GM-CSF Monoclonal Antibody TJM2 2018-12-24 11:45
I-Mab and CSPC Pharma Announce Strategic Partnership for Long-acting GLP-1 Fc Program 2018-12-17 19:10
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs 2018-11-29 15:40
MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210 2018-11-16 05:01
I-Mab and Genexine Announce China IND Approval for Innovative Immunotherapy 2018-11-02 21:11
First Patient Dosing achieved in Mainland China in a Phase II Multi-regional clinical trial (MRCT) 2018-10-12 14:01
I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Three Bispecific Antibody Programs 2018-09-26 21:27
I-Mab Wins Frost & Sullivan "2018 Best R&D Innovator Award (Biopharma Category)" 2018-09-19 15:33
I-Mab's Announces China Clinical Trial Approval of Long-acting hGLP-1 to Treat Type 2 Diabetes 2018-08-09 16:16
I-Mab Biopharma and MorphoSys Announce China IND Submission of TJ202/MOR202 2018-08-08 09:01
I-Mab Biopharma Announces New CFO 2018-08-01 08:44
I-Mab Biopharma and ABL Bio Announce Global Collaboration on Innovative Bispecific Antibodies 2018-07-26 21:30
I-Mab Successfully Raised USD 220 Million in Series C Funding 2018-06-29 18:36
I-Mab Biopharma Signs Licensing Agreement for HyLeukin With Genexine 2017-12-25 19:50
I-Mab Biopharma Partners with MorphoSys on Cancer Investigational Medicine 2017-12-01 15:55
1 4 5 6 7 8